Important Study Illuminates Role That Vitamin D Deficiency Plays in IBD and Cancer

April 30, 2014

Nutraceutical Manufacturer, GI for Life, recommends Vitamin D testing after new study highlights increased risk of cancer in individuals with IBD and low plasma 25-hydroxy vitamin D (25[OH]D) levels.

Santa Rosa, CA (PRWEB) April 30, 2014

A recent study published in the Journal of Clinical Gastroenterology and Hepatology explores the linkage between low vitamin D levels and the development of cancer (Primarily colon cancer) in a group of 2809 patients with inflammatory bowel diseases (IBD).

While the researchers noted that Vitamin D deficiency is common among patients with inflammatory bowel diseases (IBD), The effect of low vitamin D levels on health, other then bone density had not been studied in depth. In this study, they looked directly at the rates at which these patients with IBD went on to develop cancer, and correlated the mortality to plasma vitamin D levels.

What they found was a strong link to the eventual development of cancer, particularly colon cancer, and low plasma vitamin D levels. In fact, the researchers went on to illustrate how each 1-ng/mL increase in plasma 25(OH)D was associated with an 8% reduction in risk of colorectal cancer.

This study is another example of the risks caused by having a low plasma level of Vitamin D, and in particular the risk of development of colon cancer. GI for Life, a California Nutraceutical manufacturer, has developed Nutritional products specifically designed to improve the health of the digestive system and colon, based on years of clinical work and academic research by board certified Gastroenterologists.

Denise Lustberg, President of GI for Life said, "Clearly, vitamin D deficiency is a major risk factor in the development of numerous ailments and diseases. We are committed to producing products that improve quality of life of those suffering from this condition, and help maintain a healthy balance."

"At GI for Life, we make some of the highest quality liposomal delivery Vitamin D3 available anywhere. Our high potency 5,000 IU Liposomal Vitamin D3 is formulated based on the latest scientific evidence available. There are many vitamin D options on the market, but very few with a Liposomal delivery like ours. Vitamin D is better absorbed with fat so it is more readily absorbable by the body. Our liposomal vitamin D contains no sugar, salt, yeast, wheat, gluten, corn, soy, dairy, and no preservatives, artificial colors or artificial flavors."

With the high prevalence of Vitamin D deficiency, and the major risks associated with it, GI for Life recommends individuals have their Vitamin D levels tested by their primary health provider. You owe it to yourself to take simple steps to protect the long term health of your body, by monitoring and supplementing Vitamin D as directed by your health provider.

We believe healthy living starts from the inside (TM).

Colon cancer is one of the most preventable cancers if the proper steps are taken. Here at GI for Life, we embrace lifestyle changes and a nutritional prescription for digestive health based upon the latest scientific evidence on colon and intestinal health and diet. Leading board certified gastroenterologists joined forces to develop the products specifically formulated to address the nutritional needs of their patients associated with many common digestive health issues including colon cancer, celiac disease, irritable bowel syndrome, and Vitamin D deficiency. GI for Life uses the newest technology to deliver the highest quality dietary supplements.

GI for Life was founded in 2010 by board certified gastroenterologists with many years of clinical and academic experience. Dr. Michael Lustberg is a fellow of the American Gastroenterological Association. He was a section of Chief of Gastroenterology and has widely lectured on gastrointestinal health and colon cancer.

To visit the GI for Life YouTube channel, Click Here

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/05/prweb11809830.htm

Source: prweb

comments powered by Disqus